TG Therapeutics Inc Share Price Today: Live Updates & Key Insights
TG Therapeutics Inc share price today is $30.05, up -0.96%. The stock opened at $30.4 against the previous close of $30.36, with an intraday high of $30.45 and low of $29.47.
TG Therapeutics Inc Share Price Chart
TG Therapeutics Inc
TG Therapeutics Inc Share Price Performance
TG Therapeutics Inc Institutional Holdings
TG Therapeutics Inc Market Status
TG Therapeutics Inc Fundamentals
Market Cap 4801.83 M
PB Ratio 7.41
PE Ratio 10.8556
Enterprise Value 4913.57 M
Total Assets 1063.25 M
Volume 5061399
TG Therapeutics Inc Company Financials
About TG Therapeutics Inc & investment objective
Company Information TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.
Organisation Biotechnology
Employees 399
Industry Biotechnology
CEO Mr. Michael S. Weiss Esq., J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
TG Therapeutics Inc FAQs
What is the share price of TG Therapeutics Inc today?
The current share price of TG Therapeutics Inc is $30.05.
Can I buy TG Therapeutics Inc shares in India?
Yes, Indian investors can buy TG Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy TG Therapeutics Inc shares in India?
You can easily invest in TG Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy TG Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of TG Therapeutics Inc.
Can I buy fractional shares of TG Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of TG Therapeutics Inc?
TG Therapeutics Inc has a market cap of $4801.83 M.
In which sector does TG Therapeutics Inc belong?
TG Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in TG Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of TG Therapeutics Inc?
The PE ratio of TG Therapeutics Inc is 10.86 and the PB ratio is 7.41.